TOXICITY ASSOCIATED WITH COMBINATION CHEMOTHERAPY FOR OSTEO-SARCOMA - A REPORT OF THE COOPERATIVE OSTEO-SARCOMA STUDY (COSS-80)

被引：19

作者：

JURGENS, H ^{[1
]}

BERON, G ^{[1
]}

WINKLER, K ^{[1
]}

机构：

[1] UNIV HAMBURG,KINDERKLIN,D-2000 HAMBURG 13,FED REP GER

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1983年 / 106卷

关键词：

D O I：

10.1007/BF00625045

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：14 / 18

页数：5

共 21 条

[21] ADJUVANT CHEMOTHERAPY IN OSTEO-SARCOMA - EFFECTS OF CISPLATINUM, BCD, AND FIBROBLAST INTERFERON IN SEQUENTIAL COMBINATION WITH HD-MTX AND ADRIAMYCIN - PRELIMINARY-RESULTS OF THE COSS-80 STUDY [J].

WINKLER, K ;

BERON, G ;

KOTZ, R ;

SALZERKUNTSCHIK, M ;

BECK, J ;

BECK, W ;

BRANDEIS, W ;

EBELL, W ;

ERTTMANN, R ;

GOBEL, U ;

HAVERS, W ;

HENZE, G ;

HINDERFELD, L ;

HOCKER, P ;

JOBKE, A ;

JURGENS, H ;

KABISCH, H ;

LANDBECK, G ;

PREUSSER, P ;

PRINDULL, G ;

RAMACH, W ;

RITTER, J ;

SEKERA, J ;

TREUNER, J ;

WUST, G .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 :1-7

← 1 2 3 →